Veriti Management LLC Amphastar Pharmaceuticals, Inc. Transaction History

Veriti Management LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 13, 2023	SELL	$35.77 - $58.38 $155,170 - $253,252	-4,338 Reduced 48.93%	4,527 $260,000
Q1 2023 Apr 26, 2023	SELL	$27.99 - $37.92 $11,056 - $14,978	-395 Reduced 4.27%	8,865 $332,000
Q4 2022 Jan 20, 2023	SELL	$27.93 - $31.27 $17,260 - $19,324	-618 Reduced 6.26%	9,260 $0
Q3 2022 Oct 26, 2022	BUY	$27.56 - $37.75 $881 - $1,208	32 Added 0.33%	9,878 $278,000
Q2 2022 Jul 18, 2022	BUY	$29.79 - $42.29 $9,264 - $13,152	311 Added 3.26%	9,846 $343,000
Q1 2022 Apr 11, 2022	SELL	$22.96 - $36.45 $688 - $1,093	-30 Reduced 0.31%	9,535 $342,000
Q4 2021 Jan 19, 2022	BUY	$18.14 - $23.29 $173,509 - $222,768	9,565 New	9,565 $223,000
Q3 2021 Oct 08, 2021	SELL	$17.83 - $21.49 $213,050 - $256,784	-11,949 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$17.11 - $20.92 $615 - $753	36 Added 0.3%	11,949 $241,000
Q1 2021 Apr 14, 2021	BUY	$17.21 - $20.65 $5,524 - $6,628	321 Added 2.77%	11,913 $218,000
Q4 2020 Feb 11, 2021	BUY	$17.76 - $21.24 $205,873 - $246,214	11,592 New	11,592 $233,000

286

34.9M

74.3K

22.3K

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.92B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

Get notified when there are updates to the investment portfolio of Veriti Management LLC, based on Form 13F filings with the SEC.

Stay updated on Veriti Management LLC with notifications on news.